NEW YORK – Researchers in the US and China have performed single-cell RNA sequencing (scRNA-seq) analyses on colorectal cancer (CRC) cells from humans and comparable myeloid cells from mice, identifying critical cellular interactions regulating tumor immunity and defining mechanisms underlying myeloid-targeted immunotherapies.